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1. Introduction 
In order to establish a normal, in-series circulation physiologically, very different from the 
circulation in parallel which the children are born with single ventricle, doctors Fontan and 
Baudet (2) and Kreutzer (3) concurrently developed surgical treatment of patients with 
tricuspid atresia to achieve a passive flow through the pulmonary vascular bed (1). 
Management strategies for patients with functional single ventricle required a staged group 
of procedures where the ultimate goal is to have a single ventricle with a working pressure 
and volume close to normal as well as normal systemic oxygen saturation (1). It is known 
that both vascular development and lung maturation are essential for achieving benefits of 
cavopulmonary connection; the time of surgery has been defined arbitrarily and even more 
time to transition between partial to total cavopulmonary connection (1). 
Single ventricle or univentricular heart anatomically or physiologically characterized by: 
 Both atrioventricular valves attached to a single systemic ventricular chamber 
 Severe stenosis or atresia of the atrioventricular valves 
 There is no separation between the ventricles 
 One of the ventricles is hypoplastic or absent 
The essential characteristics of hypoplastic left heart syndrome syndrome are: 
1. Stenosis or atresia of the mitral valve 
2. Underdeveloped severely hypoplastic left ventricular 
3. Stenosis or aortic valve atresia 
4. Small aortic root 
5. Ductal dependent for systemic blood flow 
Thus, patients with these syndromes will have a parallel circulation in which the systemic 
and pulmonary circulations will be supplied by "mixed" blood. 
The following are the physiological characteristics of hypoplastic left heart syndrome: 
 Non-functional left ventricle 
 Pulmonary venous return directed to the right atrium through a patent foramen ovale, 
atrial septal defect or rarely, total anomalous pulmonary venous drainage 
 Mixed systemic and pulmonary venous return in right atrium 
 The right ventricle supplies the systemic and pulmonary circulation in parallel 
 Retrograde blood flow from the ductus arteriosus to the coronary arteries 
 In these patients, ductal closure would result an inadequate systemic perfusion and 
metabolic acidosis with progressive coronary ischemia, and death. 
www.intechopen.com
 
Congenital Heart Disease – Selected Aspects 
 
254 
In these patients one treatment option is repair in three stages, as follows: 
The first stage repair (Norwood operation: Classic or Sano) seeks to: 
 Provide systemic circulation: the right ventricle is used to support the systemic 
circulation 
 Ensure non-restrictive egress of the pulmonary venous return to "bypass" the left 
ventricle, the atrial septal defect is enlarged or created in the absence of (in case it did 
not exist) 
 Create an outflow tract obstruction-free system: the aorta is reconstructed 
 Provide a controlled pulmonary blood supply, creating a shunt between the systemic 
and pulmonary circulations 
 
 
Fig. 1. First Stage: The Norwood procedure with a Modified Blalock-Taussig shunt or a right 
ventricle – pulmonary artery shunt (Sano) 
The second stage repair (Glenn operation), which Takes place 6 to 8 months after-the Norwood 
is looking for: 
anastomosing the superior cava to the pulmonary artery, thus direct systemic venous return 
to the pulmonary artery, begin to create a circulation in series. Fig 2. 
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Fig. 2. Second Stage: BT shunt has been replaced with bidirectional Glenn procedure. 
The third stage repair (Fontan operation), which is performed in children 12 kg or 4 years old, 
looking for: 
anastomosing the inferior cava vein to the pulmonary artery and thus reduces the volume 
load of the single ventricle and complete the creation of a series circulation (4,5,6). Fig. 3. 
 
 
Fig. 3. Third Stage: (a) Fenestrated Fontan with lateral tunnel or (b) Fontan extra-cardiac 
conduit. 
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2. Surgical technique 
All patients were operated through a median sternotomy with extracorporeal circulation 
and moderate hypothermia. We used two techniques of total cavopulmonary anastomosis, 
according to anatomical characteristics of each patient. The technique I corresponds to the 
construction of an intracardiac lateral tunnel constructed with a patch of 
polytetrafluoroethylene (PTFE) sutured to the lateral aspect of the right atrium, thereby 
building a tunnel that diverts intracardiac blood from the inferior cava to the right 
pulmonary artery, thus completing total cavo-pulmonary connection. For these patients we 
routinely use aortic clamping and cardioplegia with blood. The technique II is interposition 
of a PTFE tube between the transected inferior cava and pulmonary artery, ipsilateral to the 
inferior cava vein, also completing total cavo-pulmonary connection. This is known as 
extracardiac Fontan. Use of aortic clamping and cardioplegia is optional according to 
surgeon’s preference. Both techniques are performed with almost routine fenestration of 4 to 
5 mm. In the technique I, a circular punch incision in the PTFE patch is made, so to 
communicate intracardiac lateral tunnel with atrial mass receiving the pulmonary venous 
return. In technique II, the fenestration is created by a similar punch incision in the lateral 
PTFE inner tube and a similar incision on the lateral aspect of the right atrium, proceeding 
to be anastomosed both holes as Luther-lateral (7.8). 
3. Type of study 
Analytical study of cross-sectional, cohort analysis. 
4. Population and sample 
We included all patients with univentricular hearts who underwent Fontan operation. We 
reviewed the records of the patients included in the univentricular heart protocol and 
database service Congenital Cardiac Surgery Cardiovascular Clinic of Santa Maria de 
Medellin (Colombia), identifying all patients undergoing the Fontan operation with 
technique total cavopulmonary anastomosis between 1994 and 2010. 
We reviewed the medical records, operative reports and echocardiograms. 
Monitoring. All patients who survived the Fontan surgery underwent clinical and 
echocardiographic follow-up. We also obtained information about procedures performed 
after surgery, medication use and functional ability (classified according to New York Heart 
Association guidelines), interviewing parents and cardiologists caring for for each patient. 
5. Results 
Management strategies in cases of functional single ventricle have come to a group of 
procedures where the goal is to obtain a ventricular pressure and volume close to normal. 
Our study demonstrated our experience in the management protocol of univentricular 
patients in total cavopulmonary connection (Fontan operation). As in other centers, the most 
commonly used technique has been the fenestrated, extra-cardiac Fontan, which in our 
study represent 58.9% of the total sample (30 patients) - Table No.1. The hospital stay was 
13.6 days on average. 
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 Frecuency Porcentage Cumulative Percentage 
Fenestrated Atriopulmonary 2 3.6 3.6
Atriopulmonary not fenestrated 1 1.8 5.4
Fenestrated Extracardiac 30 53.6 58.9
Not Fenestrated extracardiac 16 28.6 87.5
Fenestrated intracardiac 4 7.1 94.6
Not fenestrated intracardiac 3 5.4 100.0
Total 56 100,0
Table 1. Fontan type 
Frecuency Percentage Cumulative Percentage
No 48 85.7 85,7
Yes 8 14.3 100,0
Total 56 100.0
Table 2. Death 
The number of patients who failed was a total of 8; the cause in 4 of them (50% of total 
deaths) was low output syndrome which was present in the first 72 hours postoperatively, 
and the remaining 4 patients died after 72 hours after Fontan. These patients had a 
progressive deterioration associated with symptoms and signs of heart failure, protein-
losing enteropathy, persistent chylothorax, affecting directly their functional status and no 
response to medical management. These data are shown in Table No. 3. 
 
 Frecuency Percentage Cumulative Percentage
 48 85.7 85.7
Low Output 4 7.1 92.9
Fontan failed 4 7.1 100.0
Total 56 100.0
Table 3. Cause of death 
The end result is shown in Table No. 4, where 47 of them (84%) were discharged and 
continued in a functional stage I 9n 82.1% of them (Table No. 5). One patient (1.8%) sample 
was transferred from the Cardiovascular Clinic to another facility outside the country. 
 
 Frecuency Percentage Cumulative Percentage
Discharge 47 84 84
Death 8 14.2 14.2
Transfer 1 1.8 100.0
Total 56 100.0
Table 4. Cause of discharge 
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 Frecuency Percentage Cumulative Percentage
I 48 85.7 96.4 
II 1 1.8 98.2 
not evaluated 7 12.5 100.0 
Total 56 100.0  
Table 5. Current functional class 
Based on this study we conclude that the Fontan operation is a safe with a mortality rate 
comparable to that reported in previously published large series (Our series 14.3%), which is 
shown in the table No. 2. The Mayo Clinic experience, shows a overall mortality after 
Fontan, of 16%, but Many factors may have contributed to decreased early mortality after 
Fontan. Improved patient selection, younger age at time of operation, refinements in 
surgical techniques and postoperative management may all have had important roles. 
6. Discussion 
The evolution in the medium and long term outcome of patients operated with the original 
technique described by Fontan in the 70s demonstrated problems with the incorporation of 
all the systemic venous atrium in the circuit, characterized primarily by supraventricular 
arrhythmias and formation of thrombi (9,10,11). This is explained by atrial dilatation and 
inefficient circulation through this atrium which progressively becomes larger. But, changes 
in surgical techniques have been made to minimize these problems and improve long-term 
outcome (9).  
At present there are different techniques for completion of the total cavopulmonary 
diversion: the intracardiac lateral tunnel (technique I) and extracardiac conduit (Technician 
II), which are the most widely used worldwide and are just two ways that we have 
employed. We have most often used the intracardiac lateral tunnel and extracardiac conduit 
including for those patients with abnormal systemic venous return and/or lung disease, 
which is usually seen in patients with heterotaxy syndrome. Regarding the use or non use of 
fenestration, this has also been the subject of much discussion, there are groups of surgeons 
that use the fenestration routinely and others who use it selectively (12,13). We are using 
this routinely in all our patients because pulmonary vascular resistance is a dynamic 
phenomenon and therefore it is not always easy to predict its behavior during the 
postoperative period. It seems safer for the patient having a fenestration that allows you to 
maintain adequate cardiac output during periods of high pulmonary vascular resistance, 
plus helps reduce the incidence of prolonged pleural effusions, resulting in decreased 
hospital length of stay (12,13) 
With the passage of time have defined a number of criteria considered important for success 
in the performance of a Fontan-type surgery. These have included age, single ventricle 
morphology, anatomy of the pulmonary arteries, the atrioventricular valve function among 
others (14,15). 
Kirklin and colleagues (15) reported 102 patients who had Fontan between 1975 and 1985. 
They found that age less than 4 years was a risk factor for mortality. Subsequently, the 
Children`s Hospital Boston reviewed 500 patients between 1973 and 1991 and found similar 
results in relation to age (16). As for the type of functional single ventricle, these techniques 
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have been implemented for patients classically diagnosed with tricuspid atresia, but now 
with the increased survival of patients diagnosed with hypoplastic left heart syndrome, the 
question arises about the reduced ability of right ventricle to be able in time to support 
adequately the work of a single ventricle physiology to complete the process to the Fontan 
(3,17,18). This perception has not been recently supported (19.20). Mosca and colleagues 
show their results in 100 patients with Fontan performed between 1992 and 1998. They 
found no significant difference in the outcome compared to other types of single ventricle 
(21). Pizarro subsequently concluded that the Fontan can be performed safely in patients 
with SHIV making some modifications in surgical technique according to ventricular 
morphology, the mass ratio - volume and hemodynamic parameters, further suggests that 
Fontan surgery can be successful at earlier ages avoiding long exposure to hypoxia and risk 
of paradoxical embolism (1). 
Our results regarding operative mortality and mid-term survival are comparable to those 
reported by other groups. In these studies, the mortality rate varied between 0 and 27% with 
an average of 10.5% and the 5-year survival varied between 81% and 93%, with an average 
of 87.5% (9,10,22, 23). 
In relation to our surgical protocol in stages, 73.9% of patients had a bidirectional Glenn 
operation around 6 months of age, preparatory for the Fontan operation. The advantages of 
this strategy have been previously described (24,25,26). 
Regarding the use of anticoagulation, we decided to keep our patients with oral 
anticoagulation for about 6 months with the objective of preventing thrombosis at the site of 
fenestration, after this period of time, we defined the need to close the fenestration. 
This study determined that the average hospital stay was 13.9 days. 
7. Conclusions 
Management strategies in cases of functional single ventricle have come to a group of 
procedures where the goal is to obtain a ventricular pressure and volume close to normal. 
This analytical cross-sectional, cohort analysis is meant to show expertise in the 
management protocol of univentricular patients by total cavopulmonary connection (Fontan 
operation.) in Cardiovascular Clinic Santa Maria in the city of Medellin. Based on this study 
we conclude that the Fontan operation is safe with a mortality rate comparable to previously 
published large series (14.3%); the results are independent of the type of ventricle and the 
hospital length of stay is short (average hospital stay of 13.9 days). Postoperatively, is that 
over 90% of patients were in functional class I - II. 
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There are significant advances in the understanding of the molecular mechanisms of cardiac development and
the etiology of congenital heart disease (CHD). However, these have not yet evolved to such a degree so as to
be useful in preventing CHD at this time. Developments such as early detection of the neonates with serious
heart disease and their rapid transport to tertiary care centers, availability of highly sensitive noninvasive
diagnostic tools, advances in neonatal care and anesthesia, progress in transcatheter interventional
procedures and extension of complicated surgical procedures to the neonate and infant have advanced to
such a degree that almost all congenital cardiac defects can be diagnosed and "corrected". Treatment of the
majority of acyanotic and simpler cyanotic heart defects with currently available transcatheter and surgical
techniques is feasible, effective and safe. The application of staged total cavo-pulmonary connection (Fontan)
has markedly improved the long-term outlook of children who have one functioning ventricle. This book, I
hope, will serve as a rich source of information to the physician caring for infants, children and adults with CHD
which may help them provide optimal care for their patients.
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